Skip to main content
$4.02 $0.36 (9.8%)

04:00 PM EDT on 09/26/23

Abeona Therapeutics (NASDAQ:ABEO)

CAPS Rating: 1 out of 5

Current Price $4.02 Mkt Cap $90.6M
Open $3.68 P/E Ratio -1.34
Prev. Close $4.02 Div. (Yield) $0.00 (0.0%)
Daily Range $3.68 - $4.39 Volume 273,033
52-Wk Range $2.19 - $5.80 Avg. Daily Vol. 138,537


How do you think NASDAQ:ABEO will perform against the market?

Add Stock to CAPS Watchlist

All Players

12 Outperform
9 Underperform

All-Star Players

2 Outperform
6 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:ABEO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.94)
Submitted June 26, 2015

We've opened a tentative 1000 share position in Abeona with cost basis 6.8, but I have a lot of questions about this company which has arrived on trading desks via a reverse merger. Abeona has been developing AAV-based gene therapy for Sanfilippo… More

allstar31 (99.87)
Submitted January 27, 2018

Redchip stock. Pump & Dump Trash.


Recent Community Commentary

Read the most recent pitches from players about ABEO.


Member Avatar Har1en (98.32) Submitted: 8/28/2023 7:24:12 PM : Underperform Start Price: $3.90 NASDAQ:ABEO Score: -6.78

Biotech firm desperately trying to find cures to a number of ocular and skin diseases (from what I can tell). They haven't got much revenue to mention, so they primarily get funds by issuing more and more stock every year. I'm happy to flag this as underperform. Their drugs don't seem like blockbuster items. As a member of an ethical society, I applaud their efforts. As an investor... I thumb thee down.


Member Avatar allstar31 (99.87) Submitted: 1/27/2018 6:09:32 PM : Underperform Start Price: $425.00 NASDAQ:ABEO Score: +148.00

Redchip stock. Pump & Dump Trash.


Find the members with the highest scoring picks in ABEO.

No players have picked ABEO yet. Tell us why you think ABEO will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABEO.